Modifying dietary fat intake can reduce serum cholesterol in HIV-associated hypercholesterolemiaBATTERHAM, Marijka J; BROWN, Dannae; WORKMAN, Cassy et al.AIDS (London). 2003, Vol 17, Num 9, pp 1414-1416, issn 0269-9370, 3 p.Article

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patientsCAHN, Pedro; FOURIE, Jan; TOMAKA, Frank et al.AIDS (London). 2011, Vol 25, Num 7, pp 929-939, issn 0269-9370, 11 p.Article

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. CommentaryCARR, Andrew; WORKMAN, Cassy; COOPER, David A et al.Lancet (British edition). 2004, Vol 363, Num 9407, pp 412-414, issn 0140-6736, 13 p.Article

Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen : The ALLIANCE studyDWYER, Dominic E; WORKMAN, Cassy; HALES, Gillian et al.Antiviral therapy (London). 2006, Vol 11, Num 4, pp 409-419, issn 1359-6535, 11 p.Article

Molecular evidence for drug-induced compartmentalization of HIV-1 quasispecies in a patient with periodic changes to HAARTYUAN MIN WANG; DYER, Wayne B; WORKMAN, Cassy et al.AIDS (London). 2000, Vol 14, Num 15, pp 2265-2272, issn 0269-9370Article

Effects of CCR5-Δ32, CCR2-641, and SDF-1 3'A alleles on HIV-1 disease progression : An international meta-analysis of individual-patient dataIOANNIDIS, John P. A; ROSENBERG, Philip S; KOSTRIKIS, Leondios G et al.Annals of internal medicine. 2001, Vol 135, Num 9, pp 782-795, issn 0003-4819Article

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysisMILLS, Anthony M; NELSON, Mark; LAVREYS, Ludo et al.AIDS (London). 2009, Vol 23, Num 13, pp 1679-1688, issn 0269-9370, 10 p.Article

HLA-B*5701 Screening for Hypersensitivity to AbacavirMALLAL, Simon; PHILLIPS, Elizabeth; HAY, Phillip et al.The New England journal of medicine. 2008, Vol 358, Num 6, pp 568-579, issn 0028-4793, 12 p.Article

Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: A randomized trialCARR, Andrew; WORKMAN, Cassy; COOPER, David A et al.JAMA, the journal of the American Medical Association. 2002, Vol 288, Num 2, pp 207-215, issn 0098-7484Article

Effects of boosted tipranavir and lopinavir on body composition, insulin sensitivity and adipocytokines in antiretroviral-naive adultsCARR, Andrew; RITZHAUPT, Armin; WEI ZHANG et al.AIDS (London). 2008, Vol 22, Num 17, pp 2313-2321, issn 0269-9370, 9 p.Article

Correlates of antiviral immune restoration in acute and chronic HIV type 1 infection: Sustained viral suppression and normalization of T cell subsetsDYER, Wayne B; KUIPERS, Harmjan; COOLEN, Marcel W et al.AIDS research and human retroviruses. 2002, Vol 18, Num 14, pp 999-1010, issn 0889-2229, 12 p.Article

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsERON, Joseph J; YOUNG, Benjamin; KUMAR, Princy N et al.Lancet (British edition). 2010, Vol 375, Num 9712, pp 396-407, issn 0140-6736, 12 p.Article

Single-and multiple-dose pharmacokinetics of etravirine administered as two different formulations in HIV-1-infected patientsKAKUDA, Thomas N; SCHÖLLER-GYÜRE, Monika; HOETELMANS, Richard M. W et al.Antiviral therapy (London). 2008, Vol 13, Num 5, pp 655-661, issn 1359-6535, 7 p.Article

Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients : 24-Week analysis from the RESIST-1 trialGATHE, Joseph; COOPER, David A; MUKWAYA, Geoffrey et al.Clinical infectious diseases. 2006, Vol 43, Num 10, pp 1337-1346, issn 1058-4838, 10 p.Article

Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension StudyMARTIN, Allison; SMITH, Don E; COOPER, David A et al.AIDS (London). 2004, Vol 18, Num 7, pp 1029-1036, issn 0269-9370, 8 p.Article